journal description

The Journal of Medical Research and Innovation (JMRI) is an award-winning and open peer-reviewed journal which covers all aspects of Medicine including cellular biology, zoology and futuristic medicine (Robotics and Artificial Intelligence in medicine). The journal will feature original research, reviews, editorials, case studies, brief communications, opinions/views, poster presentations and audios & videos. This will be of interest to medical practitioners, clinical educators, nurse practitioners and other healthcare professionals involved in the care of patients.

The journal publishes at least two issues (Bi-Annually. First issue in January and Second in July) each year. Articles are published online when ready for publication (Continuously) as Article in Press. Additional issues may be published for special events (e.g. conferences) and when special themes are addressed. 

ISSN: 2456-8139, Founder and Editor in Chief: Dr. Varshil Mehta, Publisher: MedkruxTMSponsors: Know more
Acceptance Rate (2019): 65.52%, Access: Open Access from 2020, Article Processing Charge: Know more
Index Copernicus Value-2018: 99.05, Impact Factor-2018 (Researchgate): 0.93H-Index (Google Scholar): 5
Frequency: Bi-Annual (Semi-continuous), Abbreviation: J Med Res Innov, Contact:

Latest Issues

Original Article

Influence of Varying Doses and Duration of Dietary Nitrates from Beetroot Juice on Sprint Performance in U.S. Army ROTC Cadets: A pilot study

by Melton M., Kandiah J.

Summary: Assess the effects of varying levels and duration of dietary nitrate supplementation
from beetroot juice (BR) on sprint performance in army ROTC cadets.

Review Article

Impact of Embalica Officinalis: A miracle multipurpose plant

by Anbesse R.

Summary: Plants are a major source of nutrition and health care. Embalicalofficinalis is one of the most widely used in traditional Indian medicine in different form and believed to alleviate against several disease. This article summarizes multipurpose and medicinal value of Embalicaofficinalis (EO). I reviewed the application of EO in antioxidant, antidiabetic, anticancer, antiulcer, cardioprotective activity, cytoprotective, antitussive, immunomodualation, chelating agent, and respiratory problems.

Brief Communication

Can we change autoimmunity in Type 1 Diabetes via insulin injection or oral insulin?

by Cao M.

Summary: This article reviews recent immunotherapy studies of Type 1 Diabetes (T1D) which is an autoimmune disease. Researchers show that injecting human proinsulin peptides can safely modulate the immune system and affect beta-cell function in Type 1 Diabetes, but oral insulin consumption does not reduce the onset of Type 1 Diabetes in individuals at the early stage of the disease.

Review Article

Epidemiological Burden of Lower Limb Spasticity in Adults: A Systematic Review

by Javed M., Ali M.

Summary: The objective of this study was to investigate the burden of disease associated with lower limb spasticity (LLS) and its complications in adults.

Original Article

Race, Educational Attainment, and E-Cigarette Use

by Assari S., Mistry R., Bazargan M.

Summary: Although higher educational attainment lowers high-risk behaviors such as substance use, according to the Minorities’ Diminished Returns theory, the effect of educational attainment may be smaller for Blacks than Whites.

Case Series

To Evaluate Anti-HLA Antibodies Sensitization in Pre- and Post-renal Transplant Patient’s Serum: A Retrospective Case Series

by Agarwal N., Goswami S.

Summary: Introduction: In India, patients of renal failure are dependent on live related or unrelated donor. Because of poor financial condition patients do not go for DSA (Donor Specific Antibody) detection using Luminex. In absence of screening of de-novo production of DSA and don’t get proper management. As a result of which patient undergo acute rejection.

Index Copernicus Value for 2018 has been increased to 99.05 from 77.03 (2017 value)

Index Copernicus Value for 2018 has been increased to 99.05 from 77.03 (2017 value).


Congrats to JMRI team and its authors.

Subscription/Printing services

The subscription/printing for/of the Journal of Medical Research and Innovation shall be managed/handled by AkiNik Publications, New Delhi, India. The subscription charges will be ₹3000 or $120 per year.  

All subscriptions are payable in advance and all rates include postage and taxes. Issues will be sent on receipt of
payment. Subscriptions are entered on an annual basis and are subject to renewal in subsequent years.

Please fill this form: and send this form with payment to (By speed post/courier only):
Subscription Manager, AkiNik Publications
H. No. 169, Pocket C-11, Sector-3, Rohini, New Delhi-110085, India.
Ph.:+91-9711224068; E-mail:; web.:

Average peer reviewing time of JMRI

The current average peer reviewing time is appx. 7 weeks. However, the average time for the first decision made is appx. 5 weeks.

There is a possibility that the time for your paper may vary, if we do not find relevant reviewers for your paper. However, you can help us with this regard by providing the names of two reviewers who can potentially review your paper (Cannot be from your institution or who have worked with you in last one year).

Please bear with us, as we try our best to find reviewers in time. But, we promise to provide a fair and timely experience to every one of you.

JMRI shall now display and use CrossMark


We are pleased to say that JMRI shall now display CrossMark on each article published henceforth (may be even all those are already published so far).  This will enable us to provide current information of each published paper. Read more about crossmark at

No publication fees for the articles submitted in 2019

There shall be no charges for the entire 2019 year. Submit your paper soon. Lets make JMRI even better. Cheers to Researchers, Cheers to JMRI !!! 

Medkrux Research Group

After getting many request to start a research group, we have finally started one for all medicos. To read more kindly visit:

Technical Error has now been resolved

Since last few days, we had a technical error and due to which both the sites ( and were not working. However, that glitch has been resolved now. We apologise for the inconvenience that caused to our readers.

More Updates